Should We Start Using OCT in Myocardial Infarction with Non-Obstructive Lesions?

In ST elevation MI, the common assessment methodology continues to the angiography; however, we all know it has certain limitations, especially when it comes to intermediate lesions or coronary dissections.  

¿Debemos comenzar a usar OCT en los IAM sin lesiones obstructivas?

Using imaging, especially high resolution such as OCT, has been looked into by some studies, but never randomized studies. 

The EROSION III is a randomized controlled study on patients with ST elevation MI who after guidewire lesion crossing should present a non-obstructive lesion (≤70%) and TIMI flow III. Predilation was excluded, but thrombus aspiration was allowed, when necessary. 

The study looked at 226 patients, 112 guided by OCT and 114 by angiography.

There were no differences between populations: mean age was 55, 80% were men, 21% were diabetic. Thrombus aspiration was done in 93% of patients and obstruction rate was 54%.

Read also: Is Increased Mitral Valve Gradient After MitraClip a Long-Term Prognostic Factor?

OCT patients saw 66% plaque rupture, 26% plaque erosion, 4.5% calcified nodules, 0.9% intimal fissure and 2.7% no evidence of obstruction or atherosclerotic lesion. 

Anterior descending infarction was more frequent in the OCT group. Also, this population presented longer procedural time.  

The OCT group saw 15% reduction in stent implantation (43.8% vs 53.8% p=0.024) and residual lesions (4.6% vs 8.7% p<0.001).

Read also: Hypertrophic Cardiomyopathy: Analyzing a Historical Series.

After one year, there were no differences in death, stroke, MI, TLR, malign arrythmia, rehospitalization for unstable angina or cardiac failure. 

Conclusion

In patients with ST elevation MI, OCT guided reperfusión compared against angiography guided reperfusión was associated with lower stent implantation rate at primary PCI. These favorable results indicate the value of OCT imaging guided reperfusión in patients with ST elevation MI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board in SOLACI.org .

Original Title: EROSION III A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.

Reference: Haibo Jia, et al. J Am Coll Cardiol Intv 2022;15:846–856.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...